Urology Doctors in Lincoln, RI Accepting Medicare

1 Urology doctors found. Showing 1 - 1

Bruce Nadjmi, Urology Medicare: Not Enrolled in Medicare Practice Location: 5 Christopher Drive, Lincoln, RI 02865 Phone: 401-723-7216    Fax: 401-723-7216

News Archive

Cryoport net revenues increase 44% to $1.2 million in fourth quarter 2015

Cryoport, Inc. today announced financial results for the three and twelve-month periods ended March 31, 2015.

Hesperos receives SBIR grant to create ‘human-on-a-chip' model to mimic Alzheimer's disease

Hesperos, Inc., announced today the receipt of a NIH Phase I Small Business Innovation Research grant from the National Institutes of Health National Institute on Aging to help create a new multi-organ "human-on-a-chip" model that can realistically mimic the biology of Alzheimer's Disease and the effects of potential new therapies under realistic human physiological conditions.

Honolulu Advertiser examines diabetes prevalence among native Hawaiians, Asian-American/Pacific islanders

Native Hawaiians have higher rates of diabetes than other Asian-American/Pacific Islanders and are more likely to die at earlier ages from the disease and its complications than whites, the Honolulu Advertiser reports.

Support for health overhaul down; GOP asks Kagan if she would recuse herself from cases on new law

Support for the new health reform law has dropped seven percentage points in the last two months, though it remains higher than when the law was first signed in March. "Forty-nine percent of Americans now disapprove of the health care reform measure, according to the poll, which was conducted July 9-12. Thirty-six percent support the law. In a May CBS News poll, 47 percent disapproved of the new laws, while 43 percent approved. While the new poll shows a recent drop in support, the numbers have still improved overall since March, when 53 percent of Americans disapproved of the new laws and 32 percent said they approved of them."

AstraZeneca signs definitive agreement to acquire Novexel

Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial drug resistance, announces today that its shareholders have signed a definitive agreement whereby Novexel shall be acquired by AstraZeneca for a total cash consideration of up to $505 million, including contingent payments and the net cash position of the company at closing.

Read more Medical News

› Verified 6 days ago